Open-label trial: Difference between revisions
No edit summary |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 11: | Line 11: | ||
[[Category:Clinical trials]] | [[Category:Clinical trials]] | ||
[[tr:Açık etiketli çalışma]] | [[tr:Açık etiketli çalışma]] |
Latest revision as of 14:30, 20 August 2012
WikiDoc Resources for Open-label trial |
Articles |
---|
Most recent articles on Open-label trial Most cited articles on Open-label trial |
Media |
Powerpoint slides on Open-label trial |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Open-label trial at Clinical Trials.gov Trial results on Open-label trial Clinical Trials on Open-label trial at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Open-label trial NICE Guidance on Open-label trial
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Open-label trial Discussion groups on Open-label trial Patient Handouts on Open-label trial Directions to Hospitals Treating Open-label trial Risk calculators and risk factors for Open-label trial
|
Healthcare Provider Resources |
Causes & Risk Factors for Open-label trial |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
An open-label trial is a type of clinical trial in which both the researchers and participants know which treatment is being administered. This contrasts with single blind and double blind experimental designs, where participants are not aware of what treatment they are receiving (researchers are also unaware in a double blind trial). An open-label trial may still be randomized.